News

Keep up to date with the latest news items from GAFFI.

Berwick report on patient safety in the NHS (UK)

August 20, 2013

WHO reinstates Amphotericin B and flucytosine on the Essential medicines List

August 8, 2013

Ketoconazole withdrawn by FDA, for almost all indications

July 30, 2013

Nearly 5 million Asthmatics have ABPA and could benefit from Antifungal Therapy

May 8, 2013

Better Treatment For Cryptococcal Meningitis With Flucytosine In Combination With Amphotericin B

April 22, 2013

Access To Diagnosis And Treatment For Cryptococcal Meningitis

April 2, 2013

Ecdc Issues Risk Assessment On Azole Resistance In Aspergillus From Environmental Azole Fungicide.

February 28, 2013

Gaffi Advisers Meet Who’s Tuberculosis Leader Mario Raviglione

January 22, 2013

Hidden Killers: Human Fungal Infections – Call For Action

December 28, 2012

Global Burden of Disease 2010

December 18, 2012

GAFFI is the sole organization committed to enhancing the diagnosis, facilitating access to treatment, and improving outcomes in HIV-associated fungal disease.